![](/img/cover-not-exists.png)
Effects of switching from a dipeptidyl peptidase-4 inhibitor to luseogliflozin on nocturnal blood pressure in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, blinded endpoint parallel-group comparison study
Kameda, Reina, Nomoto, Hiroshi, Cho, Kyu Yong, Kawata, Shinichiro, Omori, Kazuno, Takeuchi, Jun, Nagai, So, Kurihara, Yoshio, Aoki, Shin, Nakamura, Akinobu, Atsumi, Tatsuya, Miyoshi, HideakiVolume:
10
Journal:
BMJ Open
DOI:
10.1136/bmjopen-2019-034883
Date:
February, 2020
File:
PDF, 407 KB
2020